SomaLogic taps staff researcher to CTO role

BOULDER — SomaLogic Inc. has tapped Jason Cleveland, one of its lead researchers, as the company’s chief technology officer.

Cleveland will lead development of the company’s blood-analysis platform.

“His unique background is the balance between science, engineering and business that we need to bring proteomics to a much wider customer base,” SomaLogic Chief Operating Officer Melody Harris said in a statement.

SPONSORED CONTENT

How dispatchable resources enable the clean energy transition

Platte River must prepare for the retirement of 431 megawatts (MW) of dispatchable, coal-fired generation by the end of the decade and address more frequent extreme weather events that can bring dark calms (periods when there is no sun or wind).

The SomaScan platform reads thousands of proteins in a patient’s blood or urine sample that may signal illnesses or future health conditions and suggest potential treatments via machine learning analysis. SomaLogic raised $214 million in venture capital late last year to fund the test’s further commercialization to clinical drug companies.

Cleveland joined SomaLogic as a principal research fellow in 2018 and was a consultant to the company for three years prior. Prior to that, he was CEO of Lab79 Technologies Inc., a DNA-sequencing startup spun out from the University of Colorado Boulder.

© 2021 BizWest Media LLC